Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Jeff E. Knight Insider Profile
4 Followers
Jeff E. Knight, COO at Crinetics Pharmaceuticals, holds 52.58K shares in Crinetics Pharmaceuticals (Ticker: CRNX). Most recently, Jeff E. Knight Sold $32,359 shares of Crinetics Pharmaceuticals on Mar 26, 2024 for an estimated value of 1.43M.
Profitable Transactions
1 out of 2 Profitable Transactions
Average Return
-4.20%
Average return per transaction
Time Frame
Compare to
Insider Roles
COO
Roles that Jeff E. Knight holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Sell
Date:Jul 29, 2022 - Jul 29, 2023
Return:+2.10%
The most profitable trade made by Jeff E. Knight
Jeff E. Knight's Trading History
List of latest transactions for each holding click on a transaction to see Jeff E. Knight's performance on stock
You May Also Like
Jeff E. Knight insider profile FAQ
What is the percentage of profitable transactions made by Jeff E. Knight?
The percentage of profitable transactions made by Jeff E. Knight is 50%.
What is the average return per transaction made by Jeff E. Knight?
The average return per transaction made by Jeff E. Knight is -4.20%.
What stocks does Jeff E. Knight hold?
Jeff E. Knight holds: CRNX stocks.
What was Jeff E. Knight’s latest transaction?
Jeff E. Knight latest transaction was an Informative Sell of $1.43M.
What was Jeff E. Knight's most profitable transaction?
Jeff E. Knight’s most profitable transaction was an Informative Sell of CRNX stock on July 29, 2022. The return on the trade was 2.10%.
What is Jeff E. Knight's role in Crinetics Pharmaceuticals?
Jeff E. Knight's role in Crinetics Pharmaceuticals is COO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.